Live Breaking News & Updates on Pharma Disclosure Channels

Stay updated with breaking news from Pharma disclosure channels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ET

Q1 2024 Earnings Results & Corporate Updates Webcast to be held Thursday, May 9th, 4:30 p.m. ET, register for webcast here, or at the link provided below.

. ....

Securities Exchange , Lantern Pharma Inc , Exchange Commission On , Lantern Pharma , Panna Sharma , Chief Executive Officer , Starlight Therapeutics , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Exchange Commission , Pharma Disclosure Channels , Disseminate Information ,

Lantern Pharma Launches "Webinar Wednesdays" Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development

Webinar Wednesdays is planned to be held on the last Wednesday of each month - starting on Wednesday, April 24th with the first webinar on the increasing prevalence of non-small cell lung cancer in. ....

United States , Ar Riya , Saudi Arabia , Kishor Bhatia , Tesaro Glaxosmithkline , Igor Astsaturov , Paulf Engstrom , Reggie Ewesuedo , Care At Fox Chase Cancer Center , Department Of Hematology Oncology , Ohio State University , Securities Exchange , Children Cancer Center Riyadh , Malignancy Program , Lantern Pharma Inc , Department Of Hematology , Marvin Concetta Greenburg Pancreatic Cancer Institute , Exchange Commission On , Clinical Development At Lantern Pharma , National Cancer Institute , Lantern Pharma , Webinar Wednesdays , Wednesday April , Starlight Therapeutics , Non Small Cell Lung , Joseph Treat ,

Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan

Approximately 33% of all non-small cell lung cancer patients in East Asia are never smokers – a growing and unaddressed patient population.

Dr. Yashushi Goto a leading lung cancer. ....

United States , Exchange Commission On , Securities Exchange , American Cancer Society , Translational Lung Cancer Research , Lantern Pharma Inc , National Cancer Center , Lantern Pharma , East Asia , Translational Lung Cancer , Yashushi Goto , East Asian , Lung Cancer , Rev Clin Oncol , Never Smokers , Tyrosine Kinases , Starlight Therapeutics , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Exchange Commission , Pharma Disclosure Channels , Disseminate Information ,

Lantern Pharma Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Operational Highlights

Lantern Pharma Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Operational Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , San Antonio , Reggie Ewesuedo , Zoltan Szallasi , Nicole Leber , Exchange Commission On , Starlight Therapeutics Inc , American Society Of Hematology , Greehey Children Cancer Research Institute , Lantern Pharma Inc , Gabrail Cancer Center , Danish Cancer Research Center , Clinical Development , Drug Administration , Harvard Medical School , Gut Health , Securities Exchange , Kennedy Krieger Institute At Johns Hopkins , Therapeutics Inc , Panna Sharma , Antonio Breast Cancer Symposium , Triple Negative Breast Cancer , Northwest Oncology , New York Cancer , Blood Specialists ,